Healionics Raises $4.7M Equity Round To Support Commercialization Of Stargraft Vascular Graft
PRIVATEMay 13, 2021
Amount Raised
$4.7 Million
Round Type
Seed
SeattleOtherHealth CareMedical
Description
Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest.
Who to call at Healionics, and when
A new round usually means Healionics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Healionics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Healionics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Healionics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Healionics
Location
2121 N. 35th Street, Suite 200
Seattle, Washington, United States
About
Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of infection and occlusion suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 33 patents issued or pending.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Healionics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SeattleOtherHealth CareMedical